Genomics firms

Privately held firms in black (listed first), publicly traded firms in red (listed second)

Listed by country of origin, then alphabetically

Updated 10 June 2001

*Patents in DNA Patent Database through Dec 31, 1999 (www.genomic.org)

 

Firm Name

Website

Public or private?

Address1

Address2

City

State

PostalCode

Country

GeneralPhone

Fax

PrimaryContact

PrimaryContactPhone

Email

Patents*

Comments

 

Bresagen

www.bresagen.com.au

Privately held

PO Box 259

Rundle Mall

Adelaide

 

5000

Australia

61-8-8234-2660

61-8-8234-6268

John Smeaton, Managing Director

 

Jsmeaton@bresagen.com

0

 
 

Exgenix

www.exgenix.com.au

Privately held

576 Swan Street

 

Richmond

Victoria

3121

Australia

61-3-9208-4444

       

0

 
 

Proteome Systems Ltd

www.proteomesystems.com

Privately held

Locked Bag 2073

 

North Ryde, 1670

NSW

2113

Australia

61-2-9889-1830

61-2-9889-1805

Keith L. Williams, CEO

 

Keith.Williams@ProteomeSystems.com

0

 
 

Advanced Array Technology SA

www.AAT-Array.com

Privately held

rue de Bruxelles 61

B-5000

Namur

   

Belgium

32-81-724151

32-81-724135

Jose Remacle, Director of Biochemistry and Cellular Biology

   

0

aat@fundp.ac.be

 

Devgen NV

www.devgen.com

Privately held

Technologiepark 9

9052 Zwijnaarde

     

Belgium

32-9-264-5402

32-9-264-5418

Theirry Bogaert, CEO and CSO

   

0

 
 

Galileo Genomics Inc.

www.galileogenomics.com

Privately held

6700 avenue du Parc

Suite 200

Montreal

Quebec

H2V 4H9

Canada

514-270-3991 ext 224

514-270-4991

Philippe Douville, VP and CBO

 

Pdouville@galileogenomics.com

0

 
 

Genechem

www.genechem.com

Privately held

1001, de Maisonneuve O.

Suite 920

Montreal

Quebec

H3A 3C8

Canada

514-849-7696

 

Louis Lacasse, President

   

0

 
 

GeneFocus

www.genefocus.com

Privately held

560 Parkside Drive

 

Waterloo

ON

N2L 5Z4

Canada

519-886-9013

519-886-8442

A. E. (Ted) Dixon, President

519-886-9013

Aedixon@confocal.com

0

Subsidiary of Biomedical Photometrics

 

Inphogene BioCom Inc.

www.inphogene.com

Privately held

309 - 4475 Wayburne Drive

 

Burnaby

BC

V5G 3L1

Canada

604.453.5900

604.453.5910

Chris Carthy, President

   

0

 
 

Integrative Proteomics Inc.

www.integrativeproteomics.com

Privately held

100 University Avenue

Tenth Floor (South Tower)

Toronto

ON

M5J 1V6

Canada

416-645-6600

416-598-1262

John Mendlein, CEO

 

Info@integrativeproteomics.com

0

 
 

Molecular Mining Corp.

www.molecularmining.com

Privately held

128 Ontario Street

 

Hamilton

ON

K7L 2Y4

Canada

613-547-9752

613-547-6835

Evan Steeg, President and CEO

 

Info@molecularmining.com

0

 
 

RabbitHutch Biotechnology Inc.

www.rabbithutch.com

Privately held

Box 506

108 Mile Ranch

 

BC

V0K 2ZO

Canada

250-791-1937

250-791-1938

   

Info@rabbithutch.com

0

 
 

Xenon Bioresearch Inc.

www.xenonbioresearch.com

Privately held

NRC Innovation Centre

3250 East Mall

Vancouver

BC

V6T 1W5

Canada

604-822-3995

604-822-4366

Frank Holler, President and CEO

   

(0)

 
 

Bios Chile IGSA

www.bioschile.cl

Privately held

Avenida Marathon

1943

Santiago

   

Chile

52-2-2381878

56-2-2394250

Pablo Valenzuela, CEO

 

Ventas@bioschile.cl

0

 
 

Inoxell AS

www.pharmexa.com for parent company. No specific Inoxell site as of 4 June 2001 (see 30 May press statement)

Privately held

6, Kogle Alle

DK-2970

Horsholm

   

Denmark

45 45 16 25 25

45 45 16 25 00

Peter Kristensen, CEO

   

0

Spun out of Pharmexa A/S 30 May 2001. Pharmexa formerly M&E Biotech. Website notes 4 patents issued (2 WO, 1 AU, 1 EP) and 7 pending patents (2 US, 2 WO, 1 KR, 1 CA, 1 JP).

 

ExonHunt Therapeutics SA

www.exonhunt.com

Privately held

65 Boulevard Massena

F-75013

Paris

   

France

33-1-53-94-77-00

33-1-53-94-77-07

Bruno Tocque, CEO

   

0

 
 

Genfit SA

www.genfit.com

Privately held

Parc Eurasante

310, avenue Eugene Avinee

59120 Loos

   

France

33-03-28-55-90-60

33-03-28-55-90-61

Jean-Charles Furchart, Chairman

   

0

 
 

GenOdyssee SA

www.genodyssee.com

Privately held

Parc d’Affaires Technopolis

3, avenue du Canada

Bat Alpha, PB 810

Courtaboef

France

Les Ulis 91974

France

33-1-69-29-80-55

33-1-69-29-80-79

Jean-Louis Escary, President and CSO;

Didier Lanson, CEO

 

Escary@genodyssee.com

0

SNP and other genomics; founded with ANVAR funds

 

Genome Express

www.genomex.com

Privately held

35 Chemin du Vieux Chêne

 

Meylan

 

38941

France

33 (0)4 76 04 16 42

33 (0)4 76 04 16 49

Francois Dohet, Marketing and Sales Manager

 

Dohet@genomex.com

0

For info in US: 1610 NE Eastgate Blvd Suite 880

Pullman, WA 99163 USA

509-332-8080

 

GenOway

www.genoway.com

Privately held

46 Allee d’Italie

69007

Lyon

   

France

33-146-02-5800

33-146-02-2511

Alexander Fraichard, CEO

   

0

 
 

Molecular Engines Laboratories

www.molecular-engines.com

Privately Held

10, rue Mercoeur

 

Paris

75011

 

France

33-1-55-25-60-63

33-1-55-25-60-73

Claude Hennion, President and CEO

 

Chennion@molecular-engines.com

0

Started firm summer 2000

 

ValiGen SA.

www.valigen.net

Privately held

Tour Neptune

92086

Paris-La-Defense

   

France

33 1 47 67 66 00

33 1 49 06 07 15

Jean-Louis Pourny, CEO

   

0

 
 

Atugen AG

www.atugen.com

Privately held

Robert-Rossle-Strasse 10

13125

Berlin

   

Germany

USA

49-30-9489-2700

49-30-9489-2701

Rudi Neirinckx, CEO, President and chairman

   

0

 
 

Biomax Informatics AG

www.biomax.de

Privately held

Lochhamer Straße 11

 

Martinsried

 

82152

Germany

49-89-89-55-74-0

49 89 89-55-74-25

Klaus Heumann, CEO

 

Info@biomax.de

0

 
 

DeveloGen AG

www.develogen.com

Privately held

Rudolf-Wisselstrasse 28

 

Gottingen

 

D-37079

Germany

49-551-505-58512

49-551-505-58586

Herbert Stadler, CEO

 

Stuart@develogen.com is COO, Edward Stuart

0

Merger of Develogen and HepaVax Oct 2000

 

Epigenomics GmbH

www.epigenomics.com

Privately held

Kastanienallee 24

D-10435

Berlin

   

Germany

49-30-24-34-5-0

49-30-24-34-5-555

Alexander Olek, President and CEO

49-30-24345-0

Olek@epigenomics.com or danek@epigenomics.com

0

 
 

FeBiT GmbH

(Perrarius Biotechnology)

www.febit.com

Privately held

Käfertalerstrasse 190

 

Mannheim

 

D-68167

Germany

49-621-3804-201

49-621-3804-400

Peer F. Staehler, CSO

   

0

 
 

Genomatix

www.genomatix.de

Privately held

 

Karlstrasse 55

München

Bavaria

D-80333

Germany

49-89-54 90 83-90

49-89-54 90 83-99

Thomas Werner, CEO

49-89-54 90 83-92

Werner@gsf.de

0

 
 

GenProfile AG

www.genprofile.com

Privately held

Robert-Rossle-Straus

D-13125

Berlin-Buch

   

Germany

49-30-9489-2150

49-30-9489-2151

Margret Hoehe (Max Delbruck Center)

   

0

 
 

GPC AG (Genome Pharmaceuticals)

www.gpc-ag.com

Privately held

Fraunhoferstrasse 20

D-82152

Martinsreid-Munich

   

Germany

49-0-89-85-65-26-00

49-0-89-85-65-26-10

Bernd Seizinger, CEO

   

8

0 for GPC but 8 for Mitotix, acquired in 2000

 

Kelman GmbH

www.kelman.de

Privately held

Innovationspark Wuhlheide, Haus 40

Koepenicker Strasse 325

Berlin

 

D-12555

Germany

49-30-6576-3600

49-30-6576-3601

Stephan Heymann, CTO

 

Info@kelman.de or genenetwork@kelman.de

0

 
 

MediGene AG

www.medigene.de

Privately held

Lochhamer Str. 11

D-82152

Planegg-Martinsreid

   

Germany

49-89-89-56-32-0

49-89-89-56-32-20

Peter Heinrich, CEO

   

0

 
 

MediGenomix GmbH

www.medigenomix.de

Privately held

Lochhamer Str.29

D-82152

Planegg/Martinsreid

   

Germany

49-0-89-89-98-92-12

49-0-89-89-98-92-90

Hanns-Georg Klein

   

0

 
 

Morphochem AG

www.morphochem.com

Privately held

Gmunder str. 37-37a

81370

Muenchen

   

Germany

49-0-89-78005-0

49-0-89-78005-555

Lutz Weber, CEO

 

Info@morphochem.com

0

 
 

MWG Biotech AG

www.mwg.biotech.com

Privately held

Anzingerstrasse 7a

 

Ebersberg

NC

D-85560

Germany

49-0-8092-82890

49-0-8092-21084

Wolfgang Heinberg, Executive for R&D

   

0

Joint US-German firm (survey sent to German address)

 

Iceland Genomics Corp.

www.uvs.is and www.icelandgenomics.com although this second site not operating 5 Apr 01

Privately held

Urour Veroandi Skuld

Lynghalsi 10

 

Reykjavik

 

10

Iceland

354-525-3600

354-525-3608

Berhard O. Palsson, CEO

 

Uvs@uvs.is

0

 
 

EiRx Therapeutics Ltd.

www.eirxtherapeutics.com

Privately held

2800 Airport Business Park

Kinsale Road

Cork

   

Ireland

353-021-4320847

353-021-4320848

Peter Daly, CEO

 

Pdaly@eirxtherapeutics.com

0

 
 

HiberGen

www.hibergen.com

Privately held

IDA Business Park

Bray

County Wicklow

   

Ireland

353-1-276-9870

353-1-276-9888

Maurice N. Treacy, CEO

353-1-808-2438

Mtreacy@hibergen.com

0

 
 

idGENE Pharmaceuticals Ltd.

www.idgene.com

Privately held

Beit Ofer, 5 Haftzrfi Street

PO Box 34478

Jerusalem

 

91344

Israel

972-2-659-5600

972-2-659-5601

Ariel Darvasi, President and CEO

 

Contact@idgene.com

0

 
 

Proteologics Inc.

www.proteologics.com Website not operating 4/5/01

Privately held

5 Oppenheimer Street

Weizmann Science Park

Rehovot

 

76701

Israel

972-8-947-5666

972-8-947-5999

Oded Lieberman, President and CEO

 

Oded@proteologics.com or olieberman@compuserve.com

0

 
 

Dragon Genomics

www.takara.co.jp

Privately held

Takara Shuzo Co., Ltd.

Biomedical Group

Seta 3-4-1, Otsu

Shiga

520-2193

Japan

81-77-543-7247

81-77-543-9254

Makoto Moriguchi, President and CEO

 

Bio-sm@takara.co.jp

0

Parent company Takara Shuzo has 41 DPP patents

 

HuBit Genomix

www.hubitgenomix.com/eng

Privately held

Joware Hanzoumon Building 2F

2-19 Hayabusa-cho, Chiyoda-ku

Tokyo

 

102-0092

Japan

81-3-5212-3360

81-3-52123384

Hiromichi Kimura, CEO

   

0

Initially Medical Genome Systems (founded April 2000)

 

Medibic

www.medibic.com

Privately held

         

Japan

81-3-3280-3987

81-3-3280-2255

Yasuhiro Hashimoto, CEO

 

Info@medibic.com

0

 
 

SuperBioChips Laboratories Inc.

www.tissue-array.com

Privately held

824-11 Yuksam-dong

Rm 1403-2

Seoul

 

135-934

Korea

82-2-3676-8270

82-2-3676-8269

     

0

 
 

UmanGenomics AB

www.umangenomics.com

Privately held

Umestan

SE-903

Umea

 

47

Sweden

46-90-71-80-90

46-90-71-80-95

Sune Rosell, President

 

Info@umangenomics.com

0

 
 

Gene Data AG

www.genedata.com

Privately held

Maulbeerstr. 46

 

Basel

 

CH-4058

Switzerland

41 61 697 6099

41 61 697 7244

Othmar Pfannes, CEO

   

0

 
 

Geneva Bioinformatics

www.genebio.com

Privately held

25 avenue de Champel

1206

Geneva

   

Switzerland

41 22 702.99.00

41 22 702.99.99

Jenny Fichmann, COO

   

0

 
 

Galapagos Genomics BV

www.galapagosgenomics.com

Privately held

BioScience Park Leiden

Zernikedreef 6

2333 CL

Leiden

 

The Netherlands

31-71-524-87-03

31-71-524-87-04

Onno van de Stolpe, Director

   

0

Joint Belgian-Dutch firm (survey sent to Belgian address)

 

Glaucus Proteomics BV

www.glaucusprot.nl

Privately held

Regulierenring 16

Bunnik

Utrecht

 

3981 LB

The Netherlands

31-30-243-3834

31-30-243-5764

Ian Humphery-Smith, COO

 

ihs@glacusprot.nl

0

 
 

Gendaq

www.gendaq.com

Privately held

1-3 Burtonhole Lane

 

London

 

NW7 1AD

UK

44-20-8982-6738

44-20-8982-6748

Timothy Brears, CEO

 

Pr@gendaq.com

0

 
 

Inpharmatica Ltd.

Www.inpharmatica.com

Privately held

60 Charlotte Street

 

London

 

W1P 2AX

UK

44-0-207-631-4644

44-0-207-631-4844

Ken Powell, CEO

 

K.powell@inpharmatica.com

0

 
 

Microscience Ltd.

www.microscience.com

Privately held

Commonwealth Building

ICSM Hammersmith Campus

Du Cane Road

London

W12 0NN

UK

44-0-20-8383-3301

44-0-20-8383-2071

Rod Richards, CEO

 

r.richards@microscience.com

0

 
 

Oxagen Ltd.

www.oxagen.co.uk

Privately held

91 Milton Park

 

Abingdon

Oxon

OX14 4RY

UK

44-0-1235-443300

44-0-1235-443301

Christine Soden, CFO

011-44-1235-443300

c.soden@oxagen.co.uk

0

 
 

Solexa Ltd.

www.solexa.co.uk

Privately held

Chesterford Research Park

Little Chesterford, nr. Saffron Walden

Essex

 

CB10 1XL

UK

44-1799-532-306

44-1799-532-301

Nick McCooke, President

 

Harold.swerdlow@solexa.co.uk

0

 
 

Synomics

www.synomics.com

Privately held

Compass House

Vision Park, Histon

Cambridge

 

CB4 9AD

UK

44-1223-257-788

44-1226-257-888

Paula Zanella, Chairman

 

Pzanella@synomics.com

0

 
 

Acadia Pharmaceuticals, Inc.

www.acadia-pharm.com

Privately held

3911 Sorrento Valley Blvd.

 

San Diego

CA

92121

USA

619-558-2871

619-558-2872

Mark Brann, President and CSO

   

2

 
 

Adeptient

www.adeptient.com

Privately held

316 Quinnhill Avenue

 

Los Altos

CA

94024

USA

650-947-9487

 

Gokhan Percin, President and CEO

 

Percin@adeptient.com

Or info@adeptient.com

0

 
 

Alanex (owned by Agouron)

www.agouron.com

Privately held

Corporate Headquarters

10350 North Torrey Pines Rd

La Jolla

CA

92037-1020

USA

858-455-3200

858-455-3287

Alex Polinsky, Head of Alanex Research Div.

   

0

 
 

Allelix (NPS Pharmaceuticals, Inc.)

www.npsp.com

Privately held

420 Chipeta Way

 

Salt Lake City

UT

84108

USA

801-583-4939

 

Hunter Johnson, CEO and President

   

22

 
 

Alpha Gene Inc

www.alphagene.com

Privately held

260 W. Cummings Park

 

Woburn

MA

01801

USA

781-933-4446

781-933-5424

Donald J. McCarren, President and CEO

 

Info@alphagene.com

1

 
 

Anadys Pharmaceuticals Inc.

www.anadyspharma.com

Privately held

9050 Camino Santa Fe

 

San Diego

CA

92121

USA

858-530-3603

858-527-1540

Kleanthis G. Xanthopoulos, President and CEO

 

Dnelson@anadyspharma.com

1

Formed from merger of Scriptgen and Askelpios. One patent from Scriptgen.

 

AnVil Informatics Inc.

www.anvilinfo.com

Privately held

600 Suffolk Street

5th Floor North

Lowell

MA

01854-3629

USA

(978) 934-8821

(978) 937-1850

Howard Berke, CEO

 

Info@anvilinformatics.com

0

 
 

Aptagen

www.aptagen.com

Privately held

520 Huntmar Park Drive

 

Herndon

VA

20170

USA

888-Aptagen;

703-793-8000

703-793-8037

Colin Higbie, President and CEO

 

Info@aptagen.com

0

 
 

Aptus Genomics Inc.

www.aptusgenomics.com

Privately held

Maryland Technology Development Center

9700 Great Seneca Highway

Rockville

MD

20850

USA

240-453-8494

240-453-9409

Kevin Chance, President and CEO

 

Info@aptusgenomics.com

0

 
 

Arcaris Inc.

www.vegen.com

Privately held

615 Arapeen Drive

Suite 300

Salt Lake City

UT

84108

USA

801-303-0300

 

M. Scott Salka, CEO

   

2

 
 

Athersys Inc.

www.athersys.com

Privately held

3201 Carnegie Avenue

 

Cleveland

OH

44115-2634

USA

216-431-9900

216-361-9495

Gil Van Bokkelen, President and CEO

   

0

IPO registered and withdrawn, Spring 2001

 

Aviva Biosciences Corp.

www.avivabio.com

Privately held

11568-9 Sorrento Valley Road

 

San Diego

CA

92121

USA

858-259-8288

858-259-8685

Julian Yuan, President and CEO

 

Info@avivabio.com

0

 
 

Beyond Genomics Inc.

www.beyondgenomics.com

Privately held

150 Cambridge Park Drive

10th Floor

Cambridge

MA

02140

USA

617-218-1694

617-497-2244

N. Stephen Ober, President

 

Steveo@beyondgenomics.com

0

 
 

BioArray Solutions LLC

www.bioarrays.com

Privately held

120 Centennial Ave

 

Piscataway

NJ

08854

USA

   

Michael Seul, Founder

 

Mseul@bioarrays.com

0

Website lists 3 PCT patents pending and excl license to one US patent

 

BioDiscovery Inc.

www.biodiscovery.com

Privately held

11150 West Olympic Blvd

Suite 1170

Los Angeles

CA

90064

USA

(310) 966-9366

(310) 966-9346

Soheil Shams, President

 

info@biodiscovery.com

0

 
 

Biognosis Inc.

www.biognosis.com

Privately held

209 Perry Parkway

 

Gaithersburg

MD

20877

USA

301-921-6001

301-921-6011

Andrew Pergen, Vice President, Biognosis US

 

Abergen@biognosis.com or info@biognosis.com

0

 
 

Bionomix Inc.

www.bionomix.com

Privately held

1376 E. Walnut Street

 

Pasadena

CA

91106

USA

   

Derek Debe, CEO

 

Damin7@kornet.net

0

Linked to Caltech

 

Biosearch Technologies Inc.

www.biosearchtech.com

Privately held

81 Digital Drive

 

Novato

CA

94949-5750

USA

415-883-8400 or 1-800-436-6631

 

Ron Cook, President and CEO

 

Info@biosearchtech.com

0

 
 

BIOwulf Genomics Inc

 

Privately held

   

Savannah

GA

 

USA

   

Peter Farley, President and CEO

   

0

Distinct from BeoWulf Genomics, a nonprofit initiative of the Wellcome Trust for micribial pathogen sequencing

 

Blue Heron

www.blueheronbio.com

Privately held

22310 20th Avenue SE

Suite 100

Bothell

WA

98021

USA

425-368-5000

425-368-4050

Peter R. Nicholson, President and CEO

 

Info@blueheronbio.com

0

 
 

Capital Genomix Inc.

www.capitalgenomix.com

Privately held

2 Cessna Court

 

Gaithersburg

MD

20879

USA

301-948-7755

301-948-9442

William Hearl, President and CEO

240-401-7496

Captlgnomx@aol.com or bhearl@capitalgenomix.com

0

 
 

Cartesian Technologies

www.cartesiantech.com/microarray_products.htm

Privately held

17851 Sky Park Circle

Suite C

Irvine

CA

92614

USA

949-440-3680

949-622-0255

Tom Tisone, President

   

0

 
 

Celadon Laboratories Inc.

www.celadonlabs.com

Privately held

387 Technology Drive

 

College Park

MD

20741-3371

USA

301-405-7591

301-314-9592

Larry Kessner, President and CEO

 

Peterson@celadonlabs.com

0

 
 

Cellomics Inc.

www.cellomics.com

Privately held

635 William Pitt Way

 

Pittsburgh

PA

15238

USA

512-826-3600

512-826-3850

D. Lansing Taylor, President and CEO

   

1

IPO registered and withdrawn Spring 2001

 

Cellular Genomics Inc.

www.cellulargenomics.com

Privately held

25 Science Park

 

New Haven

CT

06511

USA

203-776-0829

203-776-0852

Louis A. Matis, President and CSO

   

0

 
 

CeMines Inc.

www.cemines.com

Privately held

3082 Evergreen Parkway

Suite H

Evergreen

CO

80439

USA

866-236-4637

303-679-3160

   

Support@cemines.com

0

 
 

Cereon Genomics LLC

www.cereon.com

Privately held

45 Sidney Street

 

Cambridge

MA

02139

USA

617-551-8000

617-551-1990

David Fischhoff & Mark Trusheim, co-Presidents

   

0

Subsidiary of Pharmacia, formed in partnership betw. Monsanto and Millennium; agricultural genomics

 

Cetek Corp.

www.cetek.com

Privately held

260 Cedar Hill Street

 

Marlborough

MA

01752

USA

508-229-8900

508-229-3344

James L. Waters, President and CEO

 

j.little@cetek.com

0

 
 

Chimerx Inc.

www.chimerx.com

Privately held

6143 North 60th Street

 

Milwaukee

WI

53218

USA

414-535-9506 or 800-626-7833

414-535-9508

   

Chimerx@chimerx.com

0

Reagent firm

 

Clinical MicroSensors Inc.

www.microsensor.com

Privately held

126 West Del Mar Boulevard

 

Pasadena

CA

91105

USA

(626) 584-5900

(626) 584-0909

Jon Faiz Kayyem, President and CEO

 

cms@microsensor.com

0

Website lists 12 licensed or assigned patents Nov 2000

 

Clontech

www.clontech.com

Privately held

1020 East Meadow Circle

 

Palo Alto

CA

94303

USA

650-424-8222, 800-662-2566

650-424-1352, 800-424-1350

Kenneth Fong, CEO

   

8

 
 

Cogent Neuroscience Inc.

www.cogentneuro.com

Privately held

710 West Main Street

Suite 100

Durham

NC

27701

USA

   

Max Wallace, CEO

   

0

 
 

CombiMatrix Inc.

www.combimatrix.com

Privately held

34935 SE Douglas Street

Suite 110

Snoqualmie

WA

98065

USA

425-396-5940

425-396-5949

   

Info@combimatrix.com

0

 
 

Corimba Inc.

www.corimba.com *site not working 3/5/01

Privately held

2161 Shattuck Avenue

Suite 203

Berkeley

CA

94704

USA

510-548-4574

510-548-4594

     

0

 
 

DiaDexus, LLC

www.diadexus.com

Privately held

(IPO registration filed 11/00)

3303 Octavius Drive

 

Santa Clara

CA

95054

USA

408-496-6600

408-496-5777

Patrick Plewman, CEO

 

Ir@diadexus.com

0

IPO registration (intent) filed 11/00; has exclusive licenses to several patents, noted on website

 

Digital Gene Technologies Inc.

www.dgt.com

Privately held

11149 Torrey Pines Road

 

La Jolla

CA

92037

USA

858-552-1400

858-552-8625

Richard Sutcliffe, President and CEO

 

Info@dgt.com

0

 
 

Discovery BioSciences

www.discoverybio.com

Privately held

655 NE Northlake Way

 

Seattle

WA

98105

USA

206-675-9220

206-675-1125

David T. Kingsbury, CEO and Tim Hunkapiller, President

 

Info@discoverybio.com

0

Also in Foster City, CA

 

Display Systems Biotech

www.displaysystems.com

Privately held

1260 Liberty Way

Suite B

Vista

CA

92083

USA

Denmark

760-599-0598

45-70-22-22-02

760-599-9930

45-70-23-23-04

   

Tgj@displaysystems.com

0

Also Denmark:

Vestre Teglgade 8

DK-2450 Copenhagen SV

 

DNA Dynamics

www.dnadynamics.com

Privately held

3398 Carmel Mountain Road

Suite 100

San Diego

CA

92121

USA

877.362.2633

858-523-5000

858-523-5001

Tina S. Nova, CEO

   

0

Est. March 2000

 

DNA Sciences Inc.

www.dna.com

Privately held

6540 Kaiser Drive

 

Fremont

CA

94555

USA

510-494-4000

510-494-4010

Hugh Rienhoff, Jr., Chairman and CEO

 

Info@kivagen.com

0

Formerly Kiva Genetics www.kivagen.com

 

DNAmicroarray.com

www.dnamicroarray.com

Privately held

         

USA

         

0

No address or corp info available online

 

DNAPrint Genomics

www.dnaprint.com

Privately held

1748 Independence Blvd.

Suite D1

Sarasota

FL

34234

USA

941-351-4543

941-351-7388

Anthony Frudakis, CEO and CSO

 

Dnaprint@gte.net

Dangenomics@aol.com

0

Does not have patents assigned to the firm, but the website notes the the President and CEO holds 7 patents that cover 350 genes and 2 products

 

DoubleTwist Inc.

www.doubletwist.com

Privately held

1999 Harrison Street

Suite 1100

Oakland

CA

94612

USA

510-628-0100

510-628-0108

John Couch, President and CEO

   

0

Includes Pangea (former name)

 

Egea Genomics Inc.

www.egeabiosciences.com

Privately held

4178 Sorrento Valley Boulevard

Suite F

San Diego

CA

92121

USA

858-554-1805

858-554-1806

Glen A. Evans, President and CEO

   

0

 
 

EngeneOS

www.engeneos.com

Privately held

150 CambridgePark Drive

10th floor

Cambridge

MA

02140

USA

617-497-2233

617-497-2244

Frank Lee, President and CEO

 

Mail@engeneos.com

0

 
 

Entelos Inc.

www.entelos.com

Privately held

4040 Campbell Ave

Suite 200

Menlo Park

CA

94025

USA

650-330-5200

650-330-5201

James Karis, President and CEO

 

Company_info@entelos.com

0

 
 

Eos Biotechnology Inc.

www.eosbiotech.com

Privately held

225A Gateway Blvd.

 

South San Francisco

CA

94080

USA

650-246-2300

650-583-3881

David Martin, CEO and President

   

0

 
 

Epicentre Technologies Corp.

www.epicentre.com

Privately held

1402 Emil Street

 

Madison

WI

53713

USA

608-258-8474

888-284-8474

608-258-3088

Jerome J. Jendrisak

   

4

 
 

EraGen Biosciences

www.eragen.com

Privately held

12085 Research Drive

 

Alachua

FL

32615

USA

904-462-2000

 

James Prudent, CSO

 

Info@eragen.com

0

0 Patents in DPD, but website lists 6 patents issued and 3 continuations pending, all to company co-founder Stephen A. Benner, Zurich CH and Gainesville FL as inventor; presumably licensed to EraGen

 

Fairfield Enterprises Inc.

 

Privately held

PO Box 1366

 

Los Alamos

NM

87544

USA

505-662-3115

505-662-3123

Eric Fairfield, President

 

Fairfiel@trail.com

0

Developing "alternatives to luminescence detection" for arrays, etc.

 

First Genetic Trust Inc.

www.firstgenetic.net

Privately held

8770 West Bryn Mawr Avenue

Suite 1300

Chicago

IL

60631

USA

773-867-2990

773-867-2991

Arthur L. Holden, CEO

(773) 867-2990

Aholden@firstgenetic.net

NA

Focused on privacy of genetic info as trusted intermediary

 

Gamera BioScience

www.gamerabioscience.com

Privately held

200 Boston Avenue

Suite 1850

Medford

MA

02155

USA

 

781-306-0837

John Campbell, Executive Director

   

2

 
 

GenBasix Inc.

www.genbasix.com

Privately held

1500 E. Duarte Road

 

Duarte

CA

91010

USA

626-301-8832

626-301-8912

William L. Hughes, CEO

   

0

 
 

Gene Tec

www.ncbiotech.org/genetec.htm

Privately held

205 Winterberry Ridge Drive

 

Durham

NC

27713

USA

919-493-2022

 

Marilyn Stapleton, President

 

mstapleton@ntrnet.net

6

 
 

GeneFormatics Inc

www.geneformatics.com

Privately held

5830 Oberlin Drive

Suite 200

San Diego

CA

92121-3754

USA

858-450-3331

858-450-1138

John Chiplin, President and CEO

 

Jacque@geneformatics.com Jacquelyn Fetrow, scientific founder

0

 
 

GeneGo LLC

www.genego.com

Privately held

21 Chrismar Road

 

Portage

IN

46368

USA

219-763-9756

925-362-9698

Tatiana Nikolskaya, President and CEO

 

Tatiana@genego.com

0

 
 

GeneMachines Inc.

www.genemachines.com

Privately held

935 Washington Street

 

San Carlos

CA

94070

USA

650-508-1634

650-508-1644

Scott Hunicke-Smith, CEO

   

0

 
 

GeneSeek Inc.

www.geneseek.com

Privately held

4701 Innovation Drive

 

Lincoln

NE

68521

USA

402-472-5133

402-472-4203

Abe Oommen, President and CEO

 

Aoommen@geneseek.com or help@geneseek.com

0

Genotyping and sequencing; farm animal genotyping and diagnosis

 

Genetica Inc.

www.geneticainc.com

Privately held

PO Box 99

 

Cold Spring Harbor

NY

11724

USA

516-367-8847

516-367-8874

David Beach, President

   

0

(3 Patents for a Genetica of Joinville Le Pont, France, but not same company?)

 

GeneticXchange

www.geneticxchange.com

Privately held

713 Santa Cruz Avenue

 

Menlo Park

CA

94025

USA

650-321-9573

650-321-9523

Su Yun Chung, Chief computational biologist

 

Info@geneticxchange.com

0

Collaboration with Stanford University and PharmacoGenetics Knowledge Base www.pharmgkb.org

 

GeneTrace Systems Inc.

www.genetrace.com

Privately held

1401 Harbor Bay Parkway

 

Alameda

CA

94502

USA

510-748-6000

510-748-6001

George LaMotte, CEO

 

Info@genemachines.com

1

 
 

Geneva Proteomics

www.geneprot.com

Privately held

1840 Oak Avenue

 

Evanston

IL

60202

USA

847-344-2887

847-328-8432

Cedric Loiret-Bernal, CEO

 

Cedric.loiret-bernal@geneprot.com

0

 
 

Genicon Sciences Corp.

www.geniconsciences.com

Privately held

11585 Sorrento Valley Road

 

San Diego

CA

92121

USA

(858) 793-0276

(858) 793-6791

Patrick J. Mallon, President and CEO

   

0

 
 

Genome Dynamics Inc.

 

Privately held

18247 Flower Hill Way

 

Gaithersburgh

MD

20855

USA

20879-5536

301-926-0921

     

0

 
 

Genome International Corp.

www.msn.fullfield.com/~sena

Privately held

383 D’Onofrio Drive

Suite 3

Madison

WI

53719

USA

608-833-5855

 

Periannen Senapathy, President

 

Sena@genome.com

1

 
 

Genometrix Inc.

www.genometrix.com or

www.mydna.net

Privately held

2700 Research Forest Drive

Suite B7

Woodlands

TX

77381

USA

281-465-5000

281-465-5002

Mitch Eggers, CEO

   

(0)

IPO registerd and withdrawn Spring 2001

 

Genomic Health Inc.

www.genomichealth.com

Privately held

   

Palo Alto

CA

 

USA

   

Randy Scott, CEO

 

Info@genomichealth.com

0

 
 

Genomic Profiling Systems

 

Privately held

840 Memorial Drive

 

Cambridge

MA

02139

USA

617-547-7070

617-547-6060

Roanna London

Ext. 25

roanna@genprosys.com

0

 
 

Genomics Collaborative

www.dnarepository.com or

www.getdna.com

Privately held

99 Erie Street

 

Cambridge

MA

02139

USA

617-661-2400

877-436-6649

 

Michael Pellini, President

617.661.2400, ext. 2243

Mpellini@genecoop.com

0

Formerly Genomics Cooperative

 

GenoPlex Inc.

www.evolgen.com

Privately held

6840 N. Broadway

Suite 200

Denver

CO

80021

USA

(303)429-5800

(303)429-8608

Thomas E. Johnson, VP Functional Genomics

(303)429-5800 ext. 13

Tjohnson@genoplex.com

0

 
 

Golden Helix Inc.

www.goldenhelix.com

Privately held

716 South 20th Street

 

Bozeman

MT

59718

USA

406-585-8137

406-522-1503

Christophe Lambert, Ph.D.

 

Info@goldenhelix.com

0

 
 

Iconix Pharmaceuticals Inc.

www.iconixpharm.com

Privately held

850 Maude Avenue

 

Mountain View

CA

94043

USA

650-567-5500

650-567-5545

Keith Bostian, President and CEO

   

0

 
 

Incogen (Institute for Computational Genomics)

www.incogen.com

Privately held

110 Liberty Drive

Suite 104

Clemson

SC

29631

USA

800-286-6599

864-654-0887

Maciek Sasinowski, CEO and President

 

Info@incogen.com

   
 

InGenuity

www.ingenuity.com

Privately held

2160 Gold Street, 2nd Floor

PO Box 2199

Alviso

CA

95002-2199

USA

408-957-7777

408-957-7782

Jake Leschly, President and CEO

 

Info@ingenuity.com

0

 
 

InPharmix Inc.

www.inpharmix.com

Privately held

PO Box 406

 

Greenwood

IN

46142

USA

317-422-1464

 

James P. Sluka, President

 

Jsluka@inpharmix.com

0

 
 

Integrated Genomics

www.integratedgenomics.com

Privately held

2201 W. Campbell Park Drive

 

Chicago

IL

60612

USA

312-491-0846

312-491-0856

Robert Haselkorn, President and Chairman

   

0

 
 

LabBook Inc.

www.labbook.com

Privately held

8260 Greensboro Drive

Suite 100

McLean

VA

22102

USA

703-770-2800

703-288-5512

Shawn Gree, Chairman and CEO

 

Info@labbook.com

0

 
 

LI-COR, Biotechnology Division

www.licor.com

Privately held

4421 Superior Street

PO Box 4000

Lincoln

NE

68504

USA

402-467-0700

800-645-4267

402-467-0819

     

4

 
 

LifeSpan BioSciences Inc.

www.lsbio.com

Privately held

700 Blanchard Street

 

Seattle

WA

98121

USA

206-464-1554

206-464-1723

Joseph Brown, President and CEO

 

Gene@lsbio.com

2

 
 

Mergen Ltd.

www.mergen-ltd.com

Privately held

14826 Wicks Blvd

 

San Leandro

CA

94577

USA

877.4MERGEN

877-463-7436

510-352-1988

510.352.6483

Qianjin Hu, President

   

0

 
 

MicroGenomics

www.microgenomics.com

Privately held

5935 Darwin Court

 

Carlsbad

CA

92008

USA

760-603-1286

760-603-1264

   

Info@microgenomics.com

0

 
 

Mitokor Inc.

www.mitokor.com

Privately held

11494 Sorrento Valley Road

 

San Diego

CA

92121

USA

858-793-7800

858-793-7805

Malter Moos, CEO and chairman

   

5

 
 

Molecular Reflections

www.molecularreflections.com

Privately held

6330 Nancy Ridge Drive

Suite 107

San Diego

CA

92121

USA

858-623-0193

858-623-0331

Michael I. Nerenberg, President and CTO

 

Info@molecularreflections.com

0

 
 

Molecular Staging Inc.

 

Privately held

   

New Haven

CT

 

USA

             
 

Mosaic Technologies

www.mostek.com

Privately held

1106 Commonwealth Ave.

 

Boston

MA

02215

USA

617-232-7636

617-232-7950

Michael Woehler, President and CEO

   

2

 
 

Mycometrix

www.mycometrix.com

Privately held

213 East Grand Avenue

 

South San Francisco

CA

94080

USA

650.244.1419

650.244.1423

Gajus Worthington, President and CEO

 

gajus.worthington@mycometrix.com

0

Caltech startup

 

Nanogen Inc.

www.nanogen.com

Privately held

10398 Pacific Center Court

 

San Diego

CA

92121

USA

858-410-4600

858-410-4848

Howard Birndorf, CEO

   

4

 
 

NetGenics Inc.

www.netgenics.com

Privately held

1717 E. Ninth Street

Suite 1600

Cleveland

OH

44114

USA

216-861-4007

888-861-9007

216-861-4777

Manuel J. Glynias, President and CEO

   

0

IPO registered Mar 2000, but put on hold

 

NewcoGen (Applied Genomic Technologies)

www.newcogen.com

Privately held

150 Cambridge Park Drive

 

Cambridge

MA

02140

USA

617-497-2233

617-497-2244

Noubar Afeyan, CEO

 

Noubar.afeyan@newcogen.com

0

Applied Genomic Technologies one company under NewcoGen Group

 

Odyssey Pharmaceuticals Inc.

www.odysseypharma.com

Privately held

4550 Norris Canyon road

Suite 140

San Ramon

CA

94583

USA

925-242-1941

925-242-1936

Michael J. Powell, President and CSO; Anthony Carrano, Acting Director of Research

 

Mpowell@odysseypharma.com or info@odysseypharma.com

0

 
 

OmniScience Pharmaceuticals Inc.

www.omniscience.com

Privately held

4665 S. Ash Avenue

Suite G-18

Tempe

AZ

85282-6764

USA

480-456-0145

480-456-0408

Michael Chaparian, President and CSO

   

0

 
 

Ontogeny Inc.

www.ontogeny.com

Privately held

45 Moulton Street

 

Cambridge

MA

02138

USA

617-876-0086

617-876-0866

Doros Platika, President and CEO

   

2

 
 

OriGene Technologies Inc.

www.origene.com

Privately held

6 Taft Court

Suite 300

Rockville

MD

20850

USA

301-340-3188

888-267-4436

301-340-9254

(would not give out name)

   

0

 
 

Orion Genomics LLC

www.oriongenomics.com

Privately held

4041 Forest Park Blvd.

 

Saint Louis

MO

63108

USA

314-615-6977

314-615-6975

Richard Wilson, President and CEO

   

0

 
 

Pangene Corp.

www.pangene.com

Privately held

5500 Stewart Avenue

 

Freemont

CA

94538

USA

510-360-9100

 

David Zarling, President and CEO

 

Info@pangene.com

1

Website lists 8 US and 5 WO patents

 

Paradigm Genetics

www.paradigmgenetics.com

Privately held

104 Alexander Drive, Building 2

PO Box 14528

Research Triangle Park

NC

27709

USA

919-544-5578

919-544-8193

John Ryals, President and CEO

   

0

 
 

PharmaSeq Inc.

www.pharmaseq.com

Privately held

11 Deer Park Drive

Suite 204

Monmouth

NJ

08852

USA

732-355-0100

732-355-0102

Wlodek Mandecki, President and CEO

 

Mandecki@pharmaseq.com

0

 
 

Phase-1 Molecular Toxicology Inc.

www.phase1tox.com

Privately held

2904 Rodeo Park Drive East

 

Santa Fe

NM

87505

USA

505.471.8438

505.471.8205

Vincent Kazmer, CEO

 

Contact@phase1tox.com

0

 
 

Phylonix Pharmaceuticals Inc.

www.phylonix.com

Privately held

100 Inman Street

Suite 300

Cambridge

MA

02139

USA

617-441-6700

617-441-6766

George N. Serbedzija

617-441-6700 ext. 13

George@phylonix.com

0

 
 

Physiome Sciences Inc.

www.physiome.com

Privately held

307 College Road East

 

Princeton

NJ

08540-6608

USA

609-987-1199

609-987-9393

Jeremy Levin, CEO

 

Info@physiome.com

0

 
 

Praelux Inc.

Www.praelux.com

Privately held

17 Princess Road

 

Lawrenceville

NJ

08648

USA

609-620-0220

609-620-0222

David Livingston, President and CEO

   

0

Formerly SeQ, Ltd.

 

ProCeryon Biosciences Inc.

www.proceryon.com

Privately held

309 West 82nd Street

 

New York

NY

10024

USA

212-595-1102

212-595-1156

Alessandro Monge, President and CEO

   

0

See also ProCeryon GmbH of Austria; ProCeryon renamed from King’s Beech Biosoftware

 

Protein Pathways, Inc.

www.proteinpathways.com

Privately held

Suite 304

1145 Gayley Avenue

Los Angeles

CA

90024

USA

310-208-8444

310-208-8004

Todd Yeates, Interim President;

Larry Souza, Chairman and founder

 

Jkelly@proteinpathways.com, business development

0

 
 

Protogene Laboratories Inc.

www.protogene.com

Privately held

303 Constitution Drive

 

Menlo Park

CA

94025

USA

650-289-2900

650-289-2910

Christopher R. Wolf, President and CEO

   

1

 
 

Psychiatric Genomics Inc.

www.psygenomics.com website not operating 4/5/01 placeholder site at

www.fkhealth.com/psychgenpress2.html

Privately held

19 Firstfield Road

 

Gaithersburg

MD

20878

USA

301-556-1310

310-556-1350

Michael G. Palfreyman, President and CEO

 

Mpalfreyman@psygenomics.com or mpalfreyman@aol.com

0

 
 

QIK Technology

www.qiktechnology.com

Privately held

PMB 305

423 Brookline Avenue

Boston

MA

02215

USA

617-584-7869

 

Samuel E. Driver, President

 

Info@qiktechnology.com

0

 
 

Quark Biotech Inc.

www.quarkbiotech.com

Privately held

1059 Serpentine Lane

 

Pleasanton

CA

94566

USA

800-730-5795

914-478-7497

Daniel Zurr, President and CEO

   

0

Israeli company, going public H&Q doing IPO, announced June 2000

 

Radius Biosciences Inc.

www.ultranet.com/~radius

Privately held

Box 22

 

Medfield

MA

02052

USA

508-359-8828

508-359-2940

     

0

 
 

RHeoGene LLC

www.rheogene.com

Privately held

706 Forest Street

 

Charlottesville

VA

22903

USA

804-220-3333

804-975-4301

Mohan Philip, CSO

 

Info@rheogene.com

0

 
 

SciTegic Inc.

www.scitegic.com

Privately held

4540 Kearny Villa Road

Suite 224

San Diego

CA

92123-1587

USA

858-573-8410

858-573-8412

Mathew Hahn, President and CEO

 

Support@scitegic.com

0

 
 

Selective Genetics

www.selectivegenetics.com

Privately held

11035 Roselle Street

 

San Diego

CA

92121

USA

858-625-0100

619-625-0050

Andrew Baird, CSO

 

Info@selectivegenetics.com

0

 
 

Senomyx Inc.

www.senomyx.com

Privately held

11099 Torrey Pines Drive

 

La Jolla

CA

92037

USA

(858) 646-8300

(858) 404-0752

Paul Grayson, CEO

 

Jean.lockhart@senomyx.com

0

Licensing agreements with Rockefeller, Harvard, Johns Hopkins, U Calif on olfactory and vomeronasal receptor and related genes; company focus is flavor and fragrance molecules

 

Sequitur Inc.

www.sequiturinc.com

Privately held

14 Tech Circle

Suite 210

Natick

MA

01760

USA

508-650-1459

508-650-1625

Tod Woolf, VP for technology development

508-650-1459 Ext 2

Twoof@sequiturinc.com

0

 
 

SeqWright

www.seqwright.com

Privately held

2472 Bolsover

Suite 425

Houston

TX

77005

USA

(713) 528-4363

(800) 720-4363

(713) 528-6232

Fei Lu, Head of Genotyping Dept

   

0

 
 

Signature BioScience

sig.cncoffice.com/index.html

Privately held

21125 Cabot Boulevard

 

Hayward

CA

94545

USA

510 576 2334

510 576 2434

Mark McDade, CEO

 

Info@signaturebio.com

0

 
 

Silicon Genetics

www.sigenetics.com

Privately held

935 Washington Street

 

San Carlos

CA

94070

USA

650-591-4459

650-591-5574

Andrew Conway, CEO

 

Info@sigenetics.com

0

 
 

Softberry inc.

www.softberry.com

Privately held

108 Corporate Park Drive

Suite 120

White Plains

NY

10604

USA

(914) 253-8740

(914) 253-9224

   

Softberry@softberry.com

0

 
 

Spectral Genomics Inc.

www.spectralgenomics.com

Privately held

8080 North Stadium Drive

Suite 2200

Houston

TX

77054

USA

713-797-1000

713-797-0203

Shishir Shah, Principal Scientist

 

Sshah@spectralgenomics.com or info@spectralgenomics.com

0

 
 

Spotfire

www.spotfire.com

Privately held

60 Hampshire Street

 

Cambridge

MA

02139

USA

1-800-245-4211

617-621-0381

Bill Ladd, Director of Bioinformatics

617-621-0340

Bill.Ladd@spotfire.com

0

 
 

Structural Bioinformatics Inc

www.strubix.com

Privately held

10929 Technology Place

 

San Diego

CA

92127

USA

858-675-2400

858-451-3828

Edward T. Maggio, President and CEO

 

emaggio@strubix.com

0

Subsidiary of SBI Advanced Technologies A/S

 

Structural GenomiX

www.stromix.com

Privately held

10505 Roselle Street

 

San Diego

CA

92121

USA

858-558-4850

858-558-4859

Tim Harris, CEO and President

 

Tim@stromix.com

0

 
 

Structure Function Genomics

www.monmouth.com/~spidersigns/SFG

Privately held

125 Springdale Road

 

Princeton

NJ

08540

USA

609-497-9093

 

Stephen Anderson, CEO

 

Anderson@mbcl.rutgers.edu

0

 
 

Sunol Molecular Corp.

www.sunolmolecular.com

Privately held

2810 North Commerce Parkway

 

Hollywood

FL

33025-3958

USA

954-443-8600

954-443-8610

Hing Wong, President and CEO

   

2

 
 

Super Array Inc.

www.superarray.com

Privately held

P.O. Box 34494

 

Bethesda

MD

20827-0494

USA

(301) 765-9888

(301) 765-9859

Li Shen, President

 

Info@superarray.com

0

 
 

TeleChem International Inc.

Arrayit.com

Privately held

524 E. Weddell Drive

Suite 3

Sunnyvale

CA

94089

USA

408-744-1331

408-774-1711

Rene A. Schena, President

 

Arrayit@arrayit.com

0

 
 

TurboGenomics Inc.

www.turbogenomics.com

Privately held

One Century Tower

265 Church Street

New Haven

CT

06510

USA

203-974-0470 ext 231

203-776-4074

Gregory Gardiner, President and CEO

 

Ssherman@turbogenomics.com VP operations

0

 
 

US Genomics

www.usgenomics.com

Privately held

6H Gill Street

 

Woburn

MA

01801

USA

(781) 937-5550

781-938-0060

Eugene Chan, CEO

 

Info@usgenomics.com

0

 
 

Viaken Systems Inc.

www.viaken.com

Privately held

16 South Summit Avenue

Suite 250

Gaithersburg

MD

20877

USA

301-216-3400

301-330-6950

Keith Elliston, President and CEO

 

Keith.elliston@viaken.com or info@viaken.com

0

 
 

Xanthon Inc.

www.xanthoninc.com

Privately held

104 Alexander Drive

Building 5

Research Triangle Park

NC

27709-2296

USA

919-572-0707

919-547-3723

Carole Golden, VP for R&D

   

1

 
 

Xenogen

www.xenogen.com

Privately held

860 Atlantic Avenue

 

Alameda

CA

94501

USA

510-291-6100 or 888-810-8055

510-291-6196

David W. Carter, Chair and co-CEO; Pamela A. Contag, President and co-CEO

 

Info@xenogen.com

0

IPO registered, but withdrawn April 2000

 

Xeotron Corp.

www.xeotron.com placeholder site 4/5/01

Privately held

8285 El Rio

Suite 130

Houston

TX

77054

USA

713-842-2151

713-842-9060

X. Chuan Zhou, President

 

Xczhou@Xeotron.com

0

 
 

Zygogen LLC

www.zygogen.com

Privately held

520 Kell Hall

24 Peachtree Center Avenue

Atlanta

GA

30303

USA

404-523-7309

404-523-5974

Nina Sawczuk, CEO

 

Info@zygogen.com

0

 
 

Zyomyx

www.zyomyx.com

Privately held

3911 Trust Way

 

Hayward

CA

94545

USA

510-266-7500

510-784-2569

Yasunori Kaneko, CEO

 

Info@zyomyx.com

0

 
 

Syrrx Inc.

www.syrrx.com

Privately held?

3115 Merryfield Row

 

San Diego

CA

92121

USA

858-812-1629

 

Wendell Wierenga, CEO

 

Ned@syrrx.com

0

 
 

NuTec Sciences, Life Sciences Division

www.nutecsciences.com

Privatelyheld

1201 West Peachtree Street

Suite 800

Atlanta

GA

30309

USA

404-870-3300

404-870-3310

Anthony J. Shuker, President;

Michael H. Keehan, CEO

   

0

Collab with IBM & Emory: informatics

 

Autogen Limited

www.autogenlimited.com.au

Publicly traded (ATGO Australian Stock Exchange)

210 Kings Way

 

South Melbourne

Victoria

3205

Australia

61 3 9234 1188

61 3 9234 1198

Greg Collier, Chief Scientific Officer

03 9234 1188 or 0419 897 501

autogen@awi.com.au

0

 
 

CRS Robotics Corp.

www.crsrobotics.com

Publicly traded on Toronto SE

(ROB)

5344 John Lucas Drive

 

Burlington

Ontario

L7L 6A6

Canada

(905) 332-2000

800-365-7587

(905) 332-1114

Ralph Steedman, President and CEO

   

0

 
 

Genomics One Corporation

www.genomicsone.com

Publicly traded

on Montreal Eschange (GNX)

3030 Le Carrefour Blvd.

Suite 902

Laval

Quebec

H7T 2P5

Canada

(877)684-3637

 

Dr. Suzanne Lebel, President

(450)688-4499

slebel@genomicsOne.com

0

 
 

Inex Pharmaceuticals

www.inexpharm.com

Publicly traded on Toronto Exchange

(IEX)

100-8900 Glenlyon Parkway

Glenlyon Business Park

Burnaby

BC

V5J 5J*

Canada

604-419-3200

604-419-3201

David J. Main, President and CEO

 

Info@inexpharm.com

2

 
 

SignalGene Inc.

www.signalgene.com

Publicly traded

(SGI)

8475 Christophe-Colomb Avenue

Suite 1000

Montreal

Quebec

H2M 2N9

Canada

(514)850-2400

(514)850-2424

Michael Dennis, President, Chairman, and CEO

 

Michael.dennis@signalgene.com

0

 
 

Visible Genetics

www.visiblegenetics.com

Publicly traded

(VGIN)

700 Bay Street

Suite 1000

Toronto

Ontario

M5G 1Z6

Canada

416-813-3240

416-813-3250

Richard Daly, President and CEO

 

Info@visgen.com

17

 
 

Genset SA

www.genxy.com

Publicly traded

(GENXY)

24, rue Royale

 

75008 Paris

   

France

+33 1 55 04 59 00

+33 1 55 04 59 29

Daniel Cohen, Chief Genomics Officer

 

Daniel.cohen@genset.fr

1

SurGen agreement with Royal Coll Surg/Ireland; not separately listed

 

GeneScan Europe AG

www.biochip.com

Publicly traded on Neuer Market (GEP)

Engesserstr. 4 b

79108

Freiburg

   

Germany

0761-5038-0

0761-5038-111

Ulrich Birsner, CEO

   

0

12 subsidiary companies; no DPD patents for BioChip, GeneScan, or BioRobotics, but refers to a "large patent portfolio at its disposal" and several pending patents on its website

 

LION BioScience AG

www.lionbioscience.com

Publicly traded

(LEON)

Im Neuenheimer Feld 517

 

Heidelberg

 

D 69120

Germany

49-6221-403-823

49-6221-403-835

Friedrich von Bohlen, CEO

   

0

IPO July 10, 2000

 

MorphoSys GmbH

www.morphosys.de

Publicly traded on Neuer exchange

(MOR)

Lena-Christ-Straße 48

D- 82152

Martinsreid/Munich

   

Germany

49 (0)89 89927 0

49 (0)89 89927 222

Simon E. Moroney, CEO

 

Info@morphosys.de

1

 
 

deCODE Genetics

www.decode.is

Publicly traded

(DCGN)

Lynghalsi 1

 

Rekjavik

 

IS-100

Iceland

354-577-1900

354-577-1901

Kari Stefansson, President and CEO

 

Kstefans@decode.is

0

IPO July 2000

 

Compugen Ltd.

www.cgen.com

Publicly traded

(CGEN)

72 Pinchas Rosen Street

 

Tel Aviv

 

69512

Israel

972-3-765-8585

972-3-765-8555

Mor Amitai, CEO

 

Info@cgen.com

0

Founded 1993, IPO Aug 2000

 

Keryx Biopharmaceuticals Inc.

www.keryxbiopharm.com

Publicly traded

(KERX)

Kiryat Mada 5

Har Hotzvim

Jerusalem

 

91326

Israel

972-2-541-2700

972-2-541-2701

Morris Laster, CEO

   

0

IPO June 2000

 

Biacore AB

www.biacore.com

Publicly traded

(BCOR)

Radsgatan

SE-754 50

Uppsala

   

Sweden

46 18 675700

46 18 150110

Ulf Jonsson, President

 

Develop-bia@biacore.com

2

 
 

Pyrosequencing AB

www.pyrosequencing.com

Publicly traded

(PYRO A: Stockholm)

SE-752

 

Uppsala

 

28

Sweden

46-18-565-900

46-18-516000

Erik Wallden, President and CEO

 

Info@pyrosequencing.com

0

 
 

Cytomyx

www.cytomyx.com

Publicly traded

(EPIC-CYX) on AIM

140 Science Park

 

Cambridge

 

CB4 0GF

UK

44-1223-508191

44-1223-508198

   

Info@cytomyx.com

0

Formerly Cambridge BioScience; IPO May 29.2001

 

Genetix

www.genetix.co.uk

Publicly traded (GTX.L) on FTSE

Queensway

New Milton

 

Hampshire

BH25 5NN

UK

01-425-624-600

01-425-624700

Mark Reid, CEO

   

0

Acquired Genpak Ltd. IPO November 2000

 

Oxford GlycoSciences plc

www.ogs.com

Publicly traded on London Exchange (OGS)

2 The Quadrant, Barton Lane

Abingdon Science Park

Abingdon

Oxon

OX16 3J

UK

(44)1235-543200

(44)1235-554701

Michael Kranda, CEO

(44)1235-543200

michael.kranda@ogs.co.uk

5

(Patents for Oxford gene systems =3, Oxford technologies 1, Oxford biomedica 1; See also ISIS Innovation with 7 patents)

 

Pharmagene PLC

www.pharmagene.com

Publicly traded on London Exchange

(PGN)

Orchard Road

Royston

Hertfordshire

 

SG8 5HD

UK

44 0-1763 211 600

44-1-1763-211 630

Alastair Riddell, CEO

 

Alastair.riddell@pharmagene.com

0

IPO 7/2000

 

Abgenix

www.abgenix.com

Publicly traded

(ABGX)

7601 Dumbarton Circle

 

Fremont

CA

94555

USA

(510)608-6500

(510)608-6589

R. Scott Greer, Chairman, President and CEO

   

4

 
 

Aclara Biosciences Inc.

www.aclara.com

Publicly traded

(ACLA)

1288 Pear Avenue

 

Mountain View

CA

94034

USA

650-210-1200

 

Joseph M. Limber, President and CEO

 

Jlimber@aclara.com

0

 
 

Affymetrix Inc.

www.affymetrix.com

Publicly traded

(AFFX)

3380 Central Expressway

 

Santa Clara

CA

95051

USA

(408)731-5000

(408)481-0422

Stephen Fodor, CEO

   

25

 
 

Applied Biosystems

www.appliedbiosystems.com

Publicly traded

(ABI)

850 Lincoln Centre Drive

 

Foster City

CA

94404

USA

650-638-5800

800-345-5224

650-638-5884

Michael Hunkapiller, President

   

24

Includes PerSeptive Biosystems patents (4); name reverted to Applied Biosystems July 2000 (was PE Biosystems 1997-2000)

 

Applied Molecular Evolution Inc.

www.AMEvolution.com

Publicly traded

(AMEV)

3520 Dunhill Street

 

San Diego

CA

92121

USA

858-597-4990

858-597-4950

William D. Huse

 

Lblock@amevolution.com

6

Formerly Ixsys; IPO July 2000 (Patents include Ixsys)

 

ARIAD Pharmaceuticals Inc.

www.ariad.com

Publicly traded

(ARIA)

26 Landsdowne Street

 

Cambridge

MA

02139

USA

(617)494-0400

(617)494-8144

Harvey J. Berger, Chairman and CEO

   

1

 
 

Array BioPharma

www.arraybiopharma.com

Publicly traded (ARRY)

1885 33rd Street

 

Boulder

CO

80301

USA

303-381-6600

303-449-5376

Robert E. Conway, CEO

   

0

IPO Nov 2000

 

Aurora Biosciences Corp.

www.aurorabio.com

Publicly traded

(ABSC)

11010 Torreyana Road

 

San Diego

CA

92121

USA

(619)404-6600

(619)404-6714

Timothy J. Rink, President, Chairman, and CEO

   

5

3 for Aurora; 2 for PanVera, acquired in Feb 2001;

Intention of Vertex Pharmaceuticals to purchase Aurora in Fall 2001 announced May 2001

 

AVI BioPharma

www.avibio.com

Publicly traded (AVII; AVIIW; AVIIZ)

One SW Columbia Street

Suite 1105

Portland

OR

97258

USA

503-227-0554

503-227-0751

Denis R. Burger, CEO

 

Avi@avibio.com

1

Assigned to AntiVirals Inc. (former name)

Also licensed 11 patents from Ohio State Univ, 16 from Univ Nebraska

 

AxyS Pharmaceuticals Inc.

www.axyspharm.com

Publicly traded

(AXPH)

180 Kimball Way

 

South San Francisco

CA

94080

USA

(650)829-1000

(650)829-1001

John P. Walker, Chairman and CEO

   

5

(Patents include Sequana)

 

Caliper Techologies Corp.

www.calipertech.com

Publicly traded

(CALP)

605 Fairchild Drive

 

Mountain View

CA

94043-2324

USA

650-623-0700

650-623-0500

Daniel L. Kisner, CEO and President

 

Info@calipertech.com

3

1999 annual report states the company owns 52 patents (DPD count to left contains only DNA-based patents). Most Caliper patents are in microfluidics

 

Celera Genomics

www.celera.com

Publicly traded

(CRA)

45 West Gude Drive

 

Rockville

MD

20850

USA

(877)CELERA1

(240)453-4000

J. Craig Venter, CEO

   

0

(Patents for Perken-Elmer, Applied Biosystems, PerSeptive Biosystems or PE Corp. = 63)

 

Cepheid

www.cepheid.com

Publicly traded

(CPHD)

1190 Borregas Avenue

 

Sunnyvale

CA

94089-1302

USA

408-541-4191

408-541-4192

Thomas Gutshall, CEO

   

0

 
 

Ciphergen Biosystems

www.ciphergen.com

Publicly traded

(CIPH)

6611 Dumbarton Circle

 

Freemont

CA

94555

USA

510-505-2100

510-505-2101

William E. Rich, President and CEO

   

0

IPO Sept 2000

 

Corixa

www.corixa.com

Publicly traded

(CRXA)

1124 Columbia Street

Suite 200

Seattle

WA

98104-2040

USA

206-754-5711

206-754-5715

Steven Gillis, Chairman and CEO

 

Info@corixa.com

4

 
 

CuraGen Corp.

www.curagen.com

Publicly traded

(CRGN)

555 Long Wharf Drive

11th floor

New Haven

CT

06511

USA

(888)GENOMICS

203-401-3331

Jonathan M. Rothberg, CEO

   

3

 
 

Deltagen

www.deltagen.com

Publicly traded

(DGEN)

1003 Hamilton Court

 

Menlo Park

CA

94025

USA

650-752-0200

650-752-0202

William Matthews, CEO

650-752-0208

Matthews@deltagen.com

0

IPO Aug 2000

 

Diversa Corp.

www.diversa.com

Publicly traded

(DVSA)

10665 Sorrento Valley Road

 

San Diego

CA

92121

USA

619-453-7020

619-453-7032

Terrance Bruggamen, Chairman and CEO

   

20

 
 

EXACT Sciences Corp

www.exactsciences.com

Publicly tranded (EXAS)

63 Great Road

 

Maynard

MA

01754

USA

978-897-2800

978-897-3481

Don M. Hardison,

President

 

dhardison@exactsciences.com

7

10 patents listed as of February 2000; formerly Exact Laboratories, Inc.; IPO Feb 2001

 

Exelixis Pharmaceuticals Inc.

www.exelixis.com

Publicly traded

(EXEL)

260 Littlefiled Ave.

 

South San Francisco

CA

94080

USA

650-825-2200

650-825-2205

George Scangos, President and CEO

   

0

(Website notes 2 patents, but not contained in DPD through Dec ’99)

 

Genaera

www.genaera.com

Publicly traded

(GENR)

5110 Campus Drive

 

Plymouth Meeting

PA

19462

USA

(610) 941-4020

(610) 941-5399

Roy C. Levitt, President and CEO

 

Info@genaera.com

4

Former name Magainin (to which name patents are assigned)

 

Genaissance Pharmaceuticals Inc.

www.genaissance.com

Publicly traded

(GNSC)

5 Science Park

 

New Haven

CT

06511

USA

203-773-1450

203-562-9377

Gualberto Ruano, CEO and President

   

1

 
 

Gene Logic Inc.

www.genelogic.com

Publicly traded

(GLGC)

708 Quince Orchard Road

 

Gaithersburg

MD

20878

USA

(301)987-1700

(301)987-1701

Mark D. Gessler, President and COO

   

3

(Patents include Oncormed, purchased 12/98)

 

Genetic Vectors Inc.

www.gvec.com

Publicly traded on OTC

(GVEC)

5201 NW 77th Avenue

Suite 100

Miami

FL

33166

USA

305-716-0000

305-716-0001

Mead McCabe, Jr., CEO

305-716-0000

Info@gvec.com

0

Acquired DNA Sciences, Inc (of San Diego, different from DNA Sciences, Inc above) 2/2000

 

Genome Therapeutics Corp.

www.cric.com or

www.genomecorp.com

Publicly traded

(GENE)

100 Beaver Street

 

Waltham

MA

02453-8443

USA

(781)398-2300

(781)893-9535 or -8277

Robert J. Hennessey, President, Chairman, and CEO; Bernard Seizinger, CSO

 

Robert.Hennessey@genomecorp.com

8

Patents include from Collaborative Research Labs

 

Genomic Solutions

www.genomicsolutions.com

Publicly traded

(GNSL)

4355 Varsity Drive

 

Ann Arbor

MI

48108

USA

(734)975-4800 or 877-genomic

(734)975-4808

Jeffrey S. Williams, CEO

 

Info@genomicsolutions.com

0

 
 

Genomica Corporation

www.genomica.com

Publicly traded

(GNOM)

4001 Discovery Drive

Suite 130

Boulder

CO

80303

USA

(303)402-9800

(303)402-9877

James Clemens, VP of Development

 

Clemens@genomica.com

0

IPO 28 Sept 2000

 

Human Genome Sciences Inc.

www.hgsi.com

Publicly traded

(HGSI)

9410 Key West Avenue

 

Rockville

MD

20850

USA

(301)309-8504

(301)309-8512

William Haseltine, President

   

106

(128 patents through 6/12/2000)

 

Hyseq Inc.

lyra.genesolutions.com/jsp/indexmain.jsp

www.hyseq.com

Publicly traded

(HYSQ)

670 Almanor Avenue

 

Sunnyvale

CA

94086

USA

(408)524-8100

(408)524-8141

Lewis S. Gruber, President and CEO

   

4

 
 

Illumina Inc.

www.illumina.com

Publicly traded

(ILMN)

9390 Towne Centre Drive

Suite 200

San Diego

CA

92121

USA

(858) 587-4290

(858) 587-4297

Jay Flatley, President and CEO

(858)587-4233

jflatley@illumina.com

0

 
 

Incyte Genomics Inc.

www.incyte.com

Publicly traded

(INCY)

3174 Porter Drive

 

Palo Alto

CA

94304

USA

(650)855-0555

(650)855-0572

Randal W. Scott, President and CSO

 

Randy@incyte.com

276

(474 patents through 6/12/2000)

 

InforMax Inc.

www.informaxinc.com

Publicly traded

(INMX)

6010 Executive Boulevard

10th floor

North Bethesda

MD

20852

USA

240-223-0100

301-984-2206

240-223-3201

Alexander Titomirov

   

0

IPO 28 Sept 2000

 

Invitrogen Inc.

www.invitrogen.com

Publicly traded

(IVGN)

1600 Faraday Avenue

 

Carlsbad

CA

92008

USA

800-955-6288

760-603-7201

Lyle C. Turner, Chairman and CEO

   

2

Purchasing Life Technologies; deal to close by end of 2000.

 

Large Scale Biology (and Proteomics)

www.lsbc.com

Publicly traded

(LSBC)

3333 Vaca Valley Pkwy

Suite 1000

Vacaville

CA

95688

USA

707-446-5501

707-446-3917

Robert L. Erwin, President and CEO

   

17

BioSource Technologies purchased and changed names to Large Scale Biology 1999 (count includes both Cos.); IPO Aug 2000

 

Lexicon Genetics Incorporated

www.lexicon-genetics.com see also

www.lexgen.com

Publicly traded

(LEXG)

4000 Research Forest Drive

 

The Woodlands

TX

77381-4287

USA

(281)364-0100

(281)364-0155

Arthur Sands, President and CEO

(281)364-0100

jgregory@lexgen.com

0

Knockout mouse initiative through Merck Genome Research Institute

 

Lynx Therapeutics Inc.

www.lynxgen.com

Publicly traded

(LYNX)

25861 Industrial Blvd.

 

Hayward

CA

94545

USA

(510)670-9300

(510)670-9302

Norman J. W. Russell, President and CEO

   

27

 
 

Maxygen Inc.

www.maxygen.com

Publicly traded

(MAXY)

515 Galveston Drive

 

Redwood City

CA

94063

USA

650-298-5300

650-364-2715

William P. C. Stemmer, Vice President for Research

   

1

 
 

Millennium Pharmaceuticals Inc.

www.mlnm.com

Publicly traded

(MLNM)

75 Sidney Street

 

Cambridge

MA

02139

USA

(617)679-7000

(617)374-9379

Steven H. Holtzman, Chief Business Officer

617-679-7219

holtzman@mpi.com

49

(Includes 3 for "Millenium" misspelled)

 

Molecular Devices Corp.

www.moleculardevices.com

Publicly traded NASDAQ: (MDCC)

1311 Orleans Drive

 

Sunnyvale

CA

94089

USA

800-635-5577

 

Joseph D. Keegan, President and CEO

   

0

Merger of LJL BioSystems July 2000

 

Myriad Genetics Inc.

www.myriad.com

Publicly traded

(MYGN)

320 Wakara Way

 

Salt Lake City

UT

84108

USA

(801)584-3600

(801)584-3640

Mark Skolnick, CSO

   

16

 
 

Onyx Pharmaceuticals Inc.

www.onyx-pharm.com

Publicly traded

(ONXX)

3031 Research Drive

 

Richmond

CA

94806

USA

(510)222-9700

(510)222-9758

Allan Balmain, VP for Research

   

13

 
 

Orchid BioSciences Inc.

www.orchidbio.com

or www.orchid.com

Publicly traded

(ORCH)

303 College Road East

 

Princeton

NJ

08540

USA

609-750-2200

609-750-2250

Dale Pfost, President an CEO

   

2

Started as Orchid Biocomputers Inc.

 

OSI Pharmaceuticals

www.osip.com

Publicly traded

(OSIP)

777 Old Saw Mill River Road

 

Tarrytown

NY

10591-6705

USA

914-467-6200 (Corp HQ in Uniondale 516-222-0023)

516-222-0114

Benjamin Benton, Head of Functional Genomics

914-345-6200, ext 314

Bbenton@osip.com

0

 
 

Packard Bioscience

www.packardbioscience.com

Publicly traded

(PBSC)

800 Research Parkway

 

Meriden

CT

06450

USA

203-238-2351

800-243-4422

201-329-8660

 

Emery G. Olcott, CEO

 

Mpassavant@packardbioscience.com

1

 
 

Pathogenesis Corp..

www.pathogenesis.com

Publicly traded

(PGNS)

201 Elliott Avenue West

 

Seattle

WA

98119

USA

206-467-8100

206-270-313

Wilbur H. Gantz, Chairman and CEO

   

3

 
 

Pharsight Corp.

www.pharsight.com

Publicly traded; subsidiary

NASDAQ: PHST

11230 Sorrento Valley Road

Suite 140

San Diego

CA

02121

USA

858-625-1343

650-314-3889 Mtn View

858-597-1353

Janice H. Kurth, VP Genomics

 

Jkurth@pharsight.com

0

Pharsight mainly a clinical research management firm; genomics branch started 2000

 

Protein Design Labs

www.pdl.com

Publicly traded

(PDLI)

34801 Campus Drive

 

Fremont

CA

94555-3606

USA

(650)903-3700

(650)903-3730

Laurence Jay Korn, Chairman and CEO

   

7

 
 

Rigel Inc.

www.rigel.com

Publicly traded

(RIGL)

240 E. Grand Avenue

 

South San Francisco

CA

94080

USA

650-624-1100

650-624-1101

James Gower, President and CEO

   

0

IPO 11/28/00

 

Seattle Genetics Inc.

www.seattlegenetics.com

Publicly traded

(SGEN)

22215 26th Avenue SE

Suite 3000

Bothell

WA

98021

USA

425-489-4990

425-489-4798

H. Perry Fell, CEO

   

0

IPO Mar 2001; has licenses to patents from CEO and CSO

 

Sequenom Inc.

www.sequenom.com

Publicly traded

(SQNM)

11555 Sorrento Valley Road

 

San Diego

CA

92121-1331

USA

858-350-0345

858-350-0344

Hubert Koster, President and CEO

   

8

6 Sequenom + 2 Gemini Genomics; announced acquisition of Gemini May 2001. Total of 11 issued gene patents and 89 pending; 59 issued or allowed technology patents with 96 pending between the two companies as of May 2001.

 

Targeted Genetics Corp.

www.targen.com

Publicly traded

(TGEN)

1100 Olive Way

Suite 100

Seattle

WA

98101

USA

206-623-7612

206-623-0288

H. Stewart Parker, President and CEO

   

3

 
 

Third Wave Technologies Inc.

www.twt.com

Publicly traded

(TWTI)

502 South Rosa Road

 

Madison

WI

53719

USA

888-898-2357

608-273-8933

608-273-8618

Lance Fors, CEO

   

12

Plan for acquisition by PE Biosystems announced 1/24/2000. Merger canceled 5/2000. IPO announced, delayed; occurred Feb 2001.

 

Transgenomic Inc.

www.transgenomic.com

Publicly traded

(TBIO)

5600 South 42nd Street

 

Omaha

NE

68107

USA

(402) 733-2829

(800) 369-2822

402-733-1932

Collin D'Silva, CEO

 

Info@transgenomic.com

0

Services Co., IPO 7/2000

 

Tripos

www.tripos.com

Publicly traded

(TRPS)

1699 South Hanley Road

 

Saint Louis

MO

63144-2913

USA

314-647-1099 or 800-323-2960

314-6479241

John P. McAlister III, President and CEO

 

Info@tripos.com

0

 
 

Valentis Inc.

www.valentis.com

Publicly traded (VLTS)

863A Mitten Road

 

Burlingame

CA

94010

USA

650.697.1900

650.652.1990

Banjamin F. McGraw, President and CEO

Ben@valentis.com

info@Valentis.com

4

Formed from merger of PolyMASC, GeneMedicine, and Megabios; website listed 58 Issued US patents 2/15/01

 

Variagenics Inc.

www.variagenics.com

Publicly traded

(VGNX)

60 Hampshire Street

 

Cambridge

MA

02139-1562

USA

617-588-5300

617-588-5399

Taylor Crouch, President and CEO

   

0

Pharmacogenetics, IPO 7/2000

 

Vysis Inc.

www.vysis.com

Publicly traded

(VYSI)

3100 Woodcreek Drive

 

Downers Grove

IL

60515-5400

USA

(800)553-7042

(630)271-7138

John L. Bishop, President and CEO

   

4

 
 

Xenometrix

www.xeno.com

Publicly traded

OTCBB:XENO.OB

2425 North 55th Street

 

Boulder

CO

80301-5700

USA

303-447-1773

303-447-1758

Pauline Gee, President and CEO

 

Pgee@xeno.com

1

Acquired by Discovery Partners Feb 2001 (NASDAQ: DPII); Quarterly 10QSB SEC of 2/14/01 also notes EPO patent and "similar patents" but does not further specify them.